Provided by Tiger Trade Technology Pte. Ltd.

Labcorp Holdings Inc

335.11
-0.7100-0.21%
Post-market: 335.110.00000.00%19:41 EDT
Volume:456.55K
Turnover:153.32M
Market Cap:27.11B
PE:27.75
High:337.69
Open:336.39
Low:334.42
Close:335.82
52wk High:341.80
52wk Low:244.52
Shares:80.90M
Float Shares:80.50M
Volume Ratio:0.69
T/O Rate:0.57%
Dividend:2.88
Dividend Rate:0.86%
EPS(TTM):12.08
EPS(LYR):10.46
ROE:11.73%
ROA:5.53%
PB:3.15
PE(LYR):32.04

Loading ...

Labcorp’s PGDx elio tissue complete CDx approved by FDA

TIPRANKS
·
Aug 10

Labcorp Wins FDA Approval for PGDx Elio Tissue Complete Melanoma Companion Diagnostic

Reuters
·
Aug 10

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma

THOMSON REUTERS
·
Aug 10

Labcorp SVP, Chief Accounting Officer Peter J. Wilkinson Disposes of 1,420 Shares Worth $439,103.37

Reuters
·
Aug 05

Labcorp Holdings Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Aug 05

Labcorp Holdings is Maintained at Neutral by Piper Sandler

Dow Jones
·
Aug 04

Piper Sandler Adjusts Price Target on Labcorp Holdings to $309 From $300, Maintains Neutral Rating

MT Newswires Live
·
Aug 04

Labcorp Launches FDA-Approved Pten Companion Diagnostic for Prostate Cancer

THOMSON REUTERS
·
Aug 04

Labcorp : JP Morgan Raises Target Price to $360 from $330

THOMSON REUTERS
·
Aug 03

UBS Remains a Buy on Labcorp Holdings (LH)

TIPRANKS
·
Jul 31

Labcorp Holdings is Maintained at Buy by Truist Securities

Dow Jones
·
Jul 31

Labcorp Holdings Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 31

Fulgent Genetics Q2 Revenue Rises 20% Sequentially, Sees Billing System Transition Delay

Reuters
·
Jul 31

CareDx Q2 Revenue Beats Estimates; Outlook Lifted

Reuters
·
Jul 31

Barclays Raises Labcorp Price Target to $320 From $290, Maintains Equalweight Rating

MT Newswires Live
·
Jul 31

U.S. Stocks on the MOVE-Mastercard, Starbucks, Meta

Reuters
·
Jul 30

Labcorp Releases Transcript of Q2 2026 Earnings Call Webcast Prepared Remarks

Reuters
·
Jul 30

Labcorp Exec Says Specialty Testing Business Continues to Grow Faster than Routine Testing Business, Expects Trend to Continue - Conf Call

THOMSON REUTERS
·
Jul 30

Labcorp Exec Says Oncology Patients Tend to Receive Significantly More Tests over Time than Typical Patients, Driving Higher Tests Per Accession - Conf Call

THOMSON REUTERS
·
Jul 30

Labcorp Exec Says Assumption for About 30 Basis Points Impact to 2026 Diagnostics Volume from Aca-Related Changes Remains Appropriate - Conf Call

THOMSON REUTERS
·
Jul 30